Indoco Remedies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 11, 2025
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies has filed the notice for its 78th Annual General Meeting (AGM) scheduled for Thursday, September 11, 2025, at 10:30 a.m. IST via video conferencing. The board has recommended a final dividend of ₹0.20 per equity share for FY25, with the record date set as September 4, 2025 and book closure from September 5 to 11, 2025. Remote e-voting will run from September 7 to September 10, 2025. Key AGM items include adoption of FY25 financial statements, ratification of cost auditor remuneration (₹1,80,000), appointment of A.Y. Sathe & Co. as secretarial auditor for 5 years, and re-appointment of two independent directors (Dr. Vasudha Kamat and Mr. Abhijit Gore) for a second 5-year term. The annual report highlights FY25 consolidated revenue of ₹1,665 crores, with domestic formulation business growing 10.3% to ₹934 crores, while international formulation declined sharply from ₹763 crores to ₹501 crores, and EBITDA margin stood at 6% (₹99.25 crores).
This is a routine AGM filing with limited immediate price impact, but shareholders should note the modest ₹0.20 dividend and the sharp decline in international formulation revenue (down ~34% YoY), which partially offset strong domestic growth. The re-appointment of independent directors and routine auditor ratifications are standard governance items requiring shareholder approval at the AGM.